Litcius/Paper detail

Antibody neutralisation of emerging SARS-CoV-2 subvariants: EG.5.1 and XBC.1.6

Qian Wang, Yicheng Guo, Richard M. Zhang, Jerren Ho, Hiroshi Mohri, Riccardo Valdez, David M. Manthei, Aubree Gordon, Lihong Liu, David D. Ho

2023The Lancet Infectious Diseases89 citationsDOI

Topics & Concepts

NeutralizationSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Coronavirus disease 2019 (COVID-19)VirologyAntibody2019-20 coronavirus outbreakMedicineImmunologyInternal medicineOutbreakDiseaseInfectious disease (medical specialty)SARS-CoV-2 and COVID-19 ResearchViral gastroenteritis research and epidemiologySARS-CoV-2 detection and testing
Antibody neutralisation of emerging SARS-CoV-2 subvariants: EG.5.1 and XBC.1.6 | Litcius